Articles EnDF

2025

Calvo J, Naguibneva I, Kypraios A, Gilain F, Uzan B, Gaillard B, Bellenger L, Renou L, Antoniewski C, Lapillonne H, Petit A, Ballerini P, Mancini SJ, Marchand T, Peyron JF, Pflumio F. High CD44 expression and enhanced E-selectin binding identified as biomarkers of chemoresistant leukemic cells in human T-ALL.Leukemia. 2025 Feb;39(2):323-336.

Tolu S, Hamzé R, Moreau M, Bertrand R, Janel N, Movassat J. Beta cell function and global glucose metabolism are impaired in Dp(16)1Yey mouse model of Down syndrome. Diabetes Obes Metab. 2025 Jan 13.

Gautheron G, Péraldi-Roux S, Vaillé J, Belhadj S, Patyra A, Bayle M, Youl E, Omhmmed S, Guyot M, Cros G, Guichou JF, Uzan B, Movassat J, Quignard JF, Neasta J, Oiry C. The flavonoid resokaempferol improves insulin secretion from healthy and dysfunctional pancreatic β-cells. Br J Pharmacol. 2025 Jan;182(1):52-68.

Chester M, Devillers MM, Corre R, Giton F, Souaré F, Petrovic CH, Airaud É, Quintas D, Mhaouty-Kodja S, Naulé L, Guigon CJ. Reduction in minipubertal gonadotropin levels alters reproductive lifespan and ovarian follicular loss in female mice. Hum Reprod. 2025 Feb 13.

Cluzet V, Airaud E, Tete A, Devillers MM, Petit F, Leary A, Pierre A, Li H, Day CP, Weyemi U, Chauvin S, Guigon CJ. Pharmacological inhibition of SIRT1 limits the growth of tumoral and metastatic granulosa cells by impacting mTOR, Myc and E2F pathways. Mol Cancer Ther. 2025 Apr 1.

2024

Segú H, Jalševac F, Sierra-Cruz M, Feliu F, Movassat J, Rodríguez-Gallego E, Terra X, Pinent M, Ardévol A, Blay MT. Assessing the impact of insect protein sources on intestinal health and disease: insights from human ex vivo and rat in vivo models. Food Funct. 2024 Apr 22;15(8):4552-4563.

Coant N, Rendja K, Bellini L, Flamment M, Lherminier J, Portha B, Codogno P, Le Stunff H.Role of Sphingosine Kinase 1 in Glucolipotoxicity-Induced Early Activation of Autophagy in INS-1 Pancreatic β Cells. Cells. 2024 Apr 5;13(7):636.

Le Maout C, Fahy L, Renou L, Devanand C, Duwat C, Barroca V, Le Gall M, Ballerini P, Petit A, Calvo J, Uzan B, Pflumio F, Petit V. T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including hepatocyte growth factor. Biomed Pharmacother. 2024 Aug;177:117039. 

Guillemain G, Khemtemourian L, Brehat J, Morin D, Movassat J, Tourrel-Cuzin C, Lacapere JJ. TSPO in pancreatic beta cells and its possible involvement in type 2 diabetes. Biochimie. 2024 Sep;224:104-113.

Fayad SL, Reynolds LM, Torquet N, Tolu S, Mondoloni S, Nguyen C, Siriphanh A, Justo R, Didienne S, Debray N, Viollet C, Raynaud L, Layadi Y, Fouquet C, Hannesse B, Capaz AM, Topilko T, Renier N, Mourot A, Marti F, Faure P.Individualistic reward-seeking strategies that predict response to nicotine emerge among isogenic male mice living in a micro-society. PLoS Biol. 2024 Oct 24;22(10):e3002850. 

Le Ciclé C, Pacini V, Rama N, Tauszig-Delamasure S, Airaud É, Petit F, de Beco S, Cohen-Tannoudji J, L’Hôte D. Migration des cellules gonadotropes durant l’embryogenèse hypophysaire – Rôle des facteurs de transcription NEUROD1 et NEUROD4 [Transcription factors NEUROD1 and NEUROD4 in the migration of gonadotrope cells during pituitary embryogenesis]. Med Sci (Paris). 2024 Nov;40(11):810-812.

Le Ciclé C, Cohen-Tannoudji J, L’Hôte D. Recent Advances in the Understanding of Gonadotrope Lineage Differentiation in the Developing Pituitary. Neuroendocrinology. 2024 Nov 11:1-16.

2023

Devillers MM, François CM, Chester M, Corre R, Cluzet V, Giton F, Cohen-Tannoudji J, Guigon CJ. Androgen receptor signaling regulates follicular growth and steroidogenesis in interaction with gonadotropins in the ovary during mini-puberty in mice. Front Endocrinol (Lausanne). 2023 Apr 19; 14:113068.

Portha B. Burn-out de la cellule beta-pancréatique au cours du diabète de type 2 : quels mécanismes ? EMC – Endocrinologie-Nutrition 2023;34(2):1-7

Portha B. Le diabète de type 2, une histoire de burn-out des cellules ß pancréatiques. Med Mal Metab 2023; 17: 358–367

Delangre E, Pommier G, Tolu S, Uzan B, Bailbé D, Movassat J. Lithium treatment mitigates the diabetogenic effects of chronic cortico-therapy. Biomed Pharmacother. 2023 Aug;164:114895.

Le Ciclé C, Pacini V, Rama N, Tauszig-Delamasure S, Airaud E, Petit F, deBeco S, Cohen-Tannoudji J, L’hôte D. The Neurod1/4-Ntrk3-Src pathway regulates gonadotrope cell adhesion and motility. Cell Death Discov. 2023 Sep 1;9(1):327.

Marie C, Pierre A, Mayeur A, Giton F, Corre R, Grynberg M, Cohen-Tannoudji J, Guigon CJ, Chauvin S. Dysfunction of Human Estrogen Signaling as a Novel Molecular Signature of Polycystic Ovary Syndrome. Int J Mol Sci. 2023 Nov24;24(23):16689.

2022

Gong P, Bailbé D, Tolu S Pommier G, Liu J, Movassat J. Preconceptional exposure of adult male rats to bisphenol S impairsinsulin sensitivity and glucose tolerance in their male offspring. Chemosphere 2022, 314:137691.

Liu JJ, Bailbé D, Raynal S, Carbonne C, Zhen D, Dairou J, Gausseres B, Armanet M, Domet T, Pitasi C, Movassat J, Lim C,Guillemin G, Autier V, Kergoat M, Portha B. The tryptophan/kynurenine pathway is activated in the pancreatic endocrine cellsby diabetes and its blockade improves glucose-induced insulin secretion. Biochim Biophys Acta Mol Basis Dis. (11):166509.

Motte-Signoret E, Saint-Martin C, Bellané-Chantelot C, Portha B, Boileau P. Glucocorticoid-induced hyperinsulinism in apreterm neonate with inherited ABCC8 variant. Metabolites. 2022 12(9):847.

Sjöholm A, Corbett J, Leung PS, Portha B. Editorial: Understanding the gene expression of β-cell dysfunction in diabetes. Front.Endocrinol. 2022 13:1069991.

Seal SV, Henry M, Pajot C, Holuka C, Bailbé D, Movassat J, Darnaudéry M, Turner JD. A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non-Obese Type 2 Diabetes. Front Immunol. 2022, 13:896179.

Mesto N, Bailbe D, Eskandar M, Pommier G, Gil S, Tolu S, Movassat J, Tourrel-Cuzin C. Involvement of P2Y signaling in the restoration of glucose-induced insulin exocytosis in pancreatic β cells exposed to glucotoxicity. J. Cell Physiol. 2022,237(1):881-896.

Garrel G, Rouch C, L’Hôte D, Tazi S, Kassis N, Giton F, Dairou J, Dournaud P, Gressens P, Magnan C, Cruciani- Guglielmacci C, Cohen-Tannoudji J. Disruption of Pituitary Gonadotrope Activity in Male Rats After Short- or Long-Term High-Fat Diets Is Not Associated With Pituitary Inflammation. Front Endocrinol (Lausanne). 2022 Apr 13; 13: 877999.

Cluzet V, Devillers M, Petit F, Pierre A, Giton F, Airaud E, L’Hôte D, Leary A, Genestie C, Treilleux I, Mayeur A, Katzenellenbogen JA, Kim SH, Cohen- Tannoudji J, Chauvin S, Guigon CJ. Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanism. J Pathol. 2022 Mar; 256(3): 335-348.

Hamzé R, Delangre E, Tolu S, Moreau M, Janel N, Bailbé D, Movassat J. Type 2 Diabetes Mellitus and Alzheimer’s Disease:Shared Molecular Mechanisms and Potential Common Therapeutic Targets. Int J Mol Sci. 2022 4;23(23):15287.

Mesto N, Movassat J, Tourrel-Cuzin C. P2-type purinergic signaling in the regulation of pancreatic β-cell functional plasticity as a promising novel therapeutic approach for the treatment of type 2 diabetes? Front. Endocrinol. 2022, Dec 9:13:1099152

Uzan B, J. Movassat J. Rôle des macrophages dans l’inflammation insulaire au cours du diabète de type 2. Correspondances en Métabolismes Hormones Diabètes et Nutrition. 2022, N°6 – décembre 2022.

Chauvin S, Cohen-Tannoudji J, Guigon CJ. Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies. Int J Mol Sci. 2022 Jan 3; 23(1): 512.

Devillers MM, Mhaouty-Kodja S, Guigon CJ. Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models. Int J Mol Sci. 2022 Nov 8;23(22):13695.

2021

Delangre E, Liu J, Tolu S, Maouche K, Armanet M, Cattan P, Pommier G, Bailbé D, Movassat J. Underlying mechanisms of glucocorticoid-induced β-cell death and dysfunction: a new role for glycogen synthase kinase 3. Cell Death Dis. 2021, 12(12):1136. (

Brookes O, Boland S, Lai Kuen R, Miremont D, Movassat J, Baeza-Squiban A Co-culture of type I and type II pneumocytes as a model ofalveolar epithelium. PLoS One. 2021, 16(9):e0248798.

Gong P, Bailbé D, Bianchi L, Pommier G, Liu J, Tolu S, Stathopoulou MG, Portha B, Grandjean V, Movassat J. Paternal High-Protein Diet Programs Offspring Insulin Sensitivity in a Sex-Specific Manner. Biomolecules. 2021, 11(5):751.

Bailbe D, Liu J, Gong P, Portha B. Effect of Postnatal Nutritional Environment Due to Maternal Diabetes on Beta Cell Mass Programmingand Glucose Intolerance Risk in Male and Female Offspring. Biomolecules. 2021, 11(2):179.

Bourgneuf C, Bailbé D, Lamazière A, Dupont C, Farabos D, Cohen-Tannoudji J, Monniaux D, Fève B, Movassat J, diClemente N,Racine C. The diabetic Goto-Kakizaki rat, the first spontaneous prototypical rodent model of the polycystic ovary syndrome. NatCommun. 2021, 12(1):1064.

Avet C, Paul EN, Garrel G, Grange-Messent V, L’Hôte D, Denoyelle C, Corre R, Dupret JM, Lanone S, Boczkowski J, Simon V, Cohen-Tannoudji J. Carbon Black Nanoparticles Selectively Alter Follicle-Stimulating Hormone Expression in vitro and in vivo in Female Mice. Front Neurosci. 2021 Dec 6; 15: 780698.

Pierre A, Mayeur A, Marie C, Cluzet V, Chauvin J, Frydman N, Grynberg M, Cohen-Tannoudji J, Guigon CJ, Chauvin S. Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis. Int J Mol Sci. 2021 May 10; 22(9): 5046.

Moreau M, Benhaddou S, Dard R, Tolu S, Hamzé R, Vialard F, Movassat J, Janel N. Metabolic Diseases and Down Syndrome: HowAre They Linked Together? Biomedicines. 2021, 9(2):221.

Querat B. Unconventional Actions of Glycoprotein Hormone Subunits: A Comprehensive Review. Front Endocrinol (Lausanne). 2021 Sep 21;12:731966.

2020

Gausserès B, Liu J, Foppen E, Tourrel-Cuzin C, Rodriguez Sanchez-Archidona, Delangre E, Cruciani- Guglielmacci, Pons S, MaskosU, Thorens B, Magnan C, Movassat J, Maouche K. The Constitutive Lack of α7 Nicotinic Receptor Leads to Metabolic Disorders in Mouse.Biomolecules. 2020, 16;10(7):1057. (Q2)

Pitasi CL, Liu J, Gausserès B, Pommier G, Delangre E, Armanet M, Cattan P, Mégarbane B, Hanak AS, Maouche K, Bailbé D, PorthaB, Movassat J. Implication of glycogen synthase kinase 3 in diabetes-associated islet inflammation. J Endocrinol. 2020, 244(1):133-148.

Cluzet V, Devillers M, Petit F, Chauvin S, François CM, Giton F, Genestie C, di Clemente N, Cohen-Tannoudji J, Guigon CJ. Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary. Oncogene. 2020 Feb; 39(9): 1875-1890.

Devillers M, Petit F, Giton F, François CM, Juricek L, Coumoul X, Magre S, Cohen-Tannoudji J, Guigon CJ. Age- dependent vulnerability of the ovary to AhR- mediated TCDD action before puberty: Evidence from mouse models. Chemosphere. 2020 Nov; 258:127361.

Pacini V, Petit F, Quérat B, Laverrière JN, Cohen-Tannoudji J, L’hôte D. ERα orchestrates epigenetic mechanisms initiating Sf-1 gene expression during pituitary gonadotrope cell lineage differentiation. Med Sci (Paris). 2020 Jun-Jul; 36(6-7): 562-565.

Dufour S, Quérat B, Tostivint H, Pasqualini C, Vaudry H, Rousseau K. Origin and Evolution of the Neuroendocrine Control of Reproduction in Vertebrates, With Special Focus on Genome and Gene Duplications. Physiol Rev. 2020 Apr 1;100(2):869-943.

2019

Movassat J, Delangre E, Liu J, Gu Y, Janel N. Hypothesis and Theory: Circulating Alzheimer’s-related biomarkers in type 2 diabetes.Insight from the Goto-Kakizaki rat. Front Neurol. 2019, 26;10:649.

Filhoulaud G, Benhamed F, Pagesy P, Bonner C, Fardini Y, Ilias A, Movassat J, Burnol AF, Guilmeau S, Kerr-Conte J, Pattou F, Issad T,Postic C. O-GlcNacylation Links TxNIP to Inflammasome Activation in Pancreatic β Cells. Front Endocrinol (Lausanne). 2019, 10:291.

Pacini V, Petit F, Querat B, Laverriere JN, Cohen-Tannoudji J, L’hôte D. Identification of a pituitary ERα- activated enhancer triggering the expression of Nr5a1, the earliest gonadotrope lineage-specific transcription factor. Epigenetics Chromatin. 2019 Aug 7; 12(1): 48.

Manna PR, Ahmed AU, Yang S, Narasimhan M, Cohen-Tannoudji J, Slominski AT, Pruitt K. Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective. Cancers (Basel). 2019 May 4; 11(5).

Devillers M, Petit F, Cluzet V, François CM, Giton F, Garrel G, Cohen-Tannoudji J, Guigon CJ. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. J Endocrinol. 2019 Feb 1; 240(2): 215-228.

Garrel G, Denoyelle C, L’Hôte D, Picard JY, Teixeira J, Kaiser UB, Laverrière JN, Cohen-Tannoudji J. GnRH Transactivates Human AMH Receptor Gene via Egr1 and FOXO1 in Gonadotrope Cells. Neuroendocrinology. 2019; 108(2): 65-83.

Portha B, Grandjean V, Movassat J. Mother or father: who is in the front line? Mechanisms underlying the non-genomic transmission of obesity/diabetes via the maternal or the paternal line. Nutrients. 2019, 11(2):233.

Liu JJ, Movassat J, Portha B. Emerging role of kynurenines in metabolic pathologies. Curr Opin Clin Nutr Metab Care. 2019,22(1):82-90.

Devillers M, Petit F, Cluzet V, François CM, Giton F, Garrel G, Cohen-Tannoudji J, Guigon CJ. Ovarian estradiol production during mini-puberty: importance of the cross-talk between FSH and AMH. Med Sci (Paris). 2019 Mar; 35(3): 201-203.

2018

Mallek A, Movassat J, Ameddah S, Liu J, Semiane N, Khalkhal A, Dahmani Y. Experimental diabetes induced by streptozotocin in the desertgerbil Gerbillus gerbillus and the effects of short-term 20-hhydroxyecdysone administration. Biomed Pharmacother. 2018, 102:354-361.

Avet C, Denoyelle C, L’Hôte D, Petit F, Guigon CJ, Cohen-Tannoudji J, Simon V. GnRH regulates the expression of its receptor accessory protein SET in pituitary gonadotropes. PLoS One. 2018 Jul 27; 13(7).

2017

Desrois M, Lan C, Movassat J, Bernard M. Reduced up-regulation of the nitric oxide pathway and impaired endothelial and smoothmuscle functions in the female type 2 diabetic goto-kakizaki rat heart Nutr Metab (Lond). 2017, 14:6.

Purwana, I, Liu JJ, Portha B, Buteau J. HSF1 acetylation decreases its transcriptional activity and enhances glucolipotoxicity-induced apoptosis in rat and human beta cells. Diabetologia. 2017, 60(8):1432-1441.

Pierre A, Taieb J, Giton F, Grynberg M, Touleimat S, El Hachem H, Fanchin R, Monniaux D, Cohen-Tannoudji J, di Clemente N, Racine C. Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017 Nov 1; 102(11): 3970-3978.

Simon V, Avet C, Grange-Messent V, Wargnier R, Denoyelle C, Pierre A, Dairou J, Dupret JM, Cohen-Tannoudji J. Carbon Black Nanoparticles Inhibit Aromatase Expression and Estradiol Secretion in Human Granulosa Cells Through the ERK1/2 Pathway. Endocrinology. 2017 Oct 1; 158(10): 3200-3211.

Ayrout M, Simon V, Bernard V, Binart N, Cohen-Tannoudji J, Lombès M, Chauvin S. A novel non genomic glucocorticoid signaling mediated by a membrane palmitoylated glucocorticoid receptor cross talk with GnRH in gonadotrope cells. Sci Rep. 2017 May 8; 7(1): 1537.

François CM, Petit F, Giton F, Gougeon A, Ravel C, Magre S, Cohen-Tannoudji J, Guigon CJ. A novel action of follicle-stimulating hormone in the ovary promotes estradiol production without inducing excessive follicular growth before puberty. Sci Rep. 2017 Apr 11; 7: 46222.

Lannes J, L’Hôte D, Fernandez-Vega A, Garrel G, Laverrière JN, Cohen-Tannoudji J, Quérat B. microRNA and inactivation of the pituitary gonadotrope function. Med Sci (Paris). 2017 Apr; 33(4): 386-388.

 

2025

Sonigo C, Ranisavljevic N, Guigui M, Anahory T, Mayeur A, Moutou C, Rongières C, Reignier A, Leperlier F, Melaye G, Girardet A, Ray PF, Steffann J, Pirrello O, Grynberg M. Ovarian response in preimplantation genetic testing for myotonic dystrophy type 1. J Assist Reprod Genet. 2025 Jan;42(1):185-192.

2024

Ziemska-Legiecka J, Jarnot P, Szymańska S, Błaszczyk D, Staśczak A, Langer-Macioł H, Lucińska K, Widzisz K, Janas A, Słowik H, Śliwińska W, Gruca A, Grynberg M. LCRAnnotationsDB: a database of low complexity regions functional and structural annotations. BMC Genomics. 2024 Dec 27;25(1):1251.

Ranisavljevic N, Yazbeck C, Vaugon S, Nuyttens C, Bernard C, Arcelin T, Kirion J, Baffert S, Castello-Bridoux C, Luciani L, Marino P, Grynberg M. Patient preferences on pen injectors for assisted reproductive technology: a discrete choice experiment in France. Expert Opin Drug Deliv. 2024 Dec;21(12):1897-1908.

Jardanowska-Kotuniak M, Dramiński M, Własnowolski M, Łapiński M, Sengupta K, Agarwal A, Filip A, Ghosh N, Pancaldi V, Grynberg M, Saha I, Plewczynski D, Dąbrowski MJ. Unveiling epigenetic regulatory elements associated with breast cancer development. bioRxiv [Preprint]. 2024 Nov 15:2024.11.12.623187.

Borget I, Benchaib M, Poignant P, Rey L, Harty G, Chaudhari V, D’hooghe T, Schwarze JE, Cedrin Durnerin I, Roeder C, Grynberg M. A Cost-Effectiveness Analysis of Gonadotropins Used for Ovarian Stimulation during Assisted Reproductive Technology Based on Data from the French Nationwide Claims Database (SNDS). Gynecol Obstet Invest. 2024 Nov 19:1-15.

Peigné M, Grynberg M, Sonigo C. Reply of the authors: from breast cancer to fertility outcomes: increasing understanding of urgent fertility preservation. Fertil Steril. 2025 Feb;123(2):376.

Gotschel F, Sonigo C, Becquart C, Sellami I, Mayeur A, Grynberg M. New Insights on In Vitro Maturation of Oocytes for Fertility Preservation. Int J Mol Sci. 2024 Oct 1;25(19):10605.

Morice P, Scambia G, Abu-Rustum NR, Acien M, Arena A, Brucker S, Cheong Y, Collinet P, Fanfani F, Filippi F, Eriksson AGZ, Gouy S, Harter P, Matias-Guiu X, Pados G, Pakiz M, Querleu D, Rodolakis A, Rousset-Jablonski C, Stepanyan A, Testa AC, Macklon KT, Tsolakidis D, De Vos M, Planchamp F, Grynberg M. Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE. Lancet Oncol. 2024 Nov;25(11):e602-e610.

Grynberg M, Zeghari F, Peigné M, Benoit A, Rakrouki S, Sifer C, Mayeur A, Saïs E, Sonigo C. Effect of breast cancer prognostic factors on ovarian reserve and response in fertility preservation. Reprod Biomed Online. 2024 Nov;49(5):104109.

Grynberg M, Sermondade N. Fertility preservation before cancer treatment: the dilemma of saying ‘no’ as the price of glory. Hum Reprod. 2024 May 24:deae110.

Le Poulennec T, Dubreuil S, Grynberg M, Chabbert-Buffet N, Sermondade N, Fourati S, Siffroi JP, Héron D, Bachelot A. Ovarian reserve in patients with FMR1 gene premutation and the role of fertility preservation. Ann Endocrinol (Paris). 2024 Jul;85(4):269-275.

Peigné M, Mur P, Laup L, Hamy AS, Sifer C, Mayeur A, Eustache F, Sarandi S, Vinolas C, Rakrouki S, Benoit A, Grynberg M, Sonigo C. Fertility outcomes several years after urgent fertility preservation for patients with breast cancer. Fertil Steril. 2024 Sep;122(3):504-513.

Gambini S, Sonigo C, Robin G, Cedrin-Durnerin I, Vinolas C, Sifer C, Boumerdassi Y, Mayeur A, Gallot V, Grynberg M, Peigné M. Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggering. Hum Reprod. 2024 May 2;39(5):963-973.

Sonigo C, Ahdad-Yata N, Pirtea P, Solignac C, Grynberg M, Sermondade N. Do IVF culture conditions have an impact on neonatal outcomes? A systematic review and meta-analysis. J Assist Reprod Genet. 2024 Mar;41(3):563-580.

Benvenuti C, Laot L, Grinda T, Lambertini M, Pistilli B, Grynberg M. IIs controlled ovarian stimulation safe in patients with hormone receptor-positive breast cancer receiving neoadjuvant chemotherapy? ESMO Open. 2024 Feb;9(2):102228.

Boumerdassi Y, Labrosse J, Hammami F, Dahoun M, Bouyer J, O’Neill L, Sarandi S, Peigné M, Cedrin I, Grynberg M, Sifer C. Impact of oxygen tension during in vitro maturation: a sibling-oocyte prospective double-blinded study. Fertil Steril. 2024 Apr;121(4):615-621.

Porcu-Buisson G, Maignien C, Swierkowski-Blanchard N, Rongières C, Ranisavljevic N, Oger P, Decanter C, Hocké C, Bry-Gauillard H, Grynberg M, Barrière P, Bernot M, Guivarc’h-Levêque A. Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF/ICSI procedures (DELTA Study). Eur J Obstet Gynecol Reprod Biol. 2024 Feb;293:21-26.

Feferkorn I, Santos-Ribeiro S, Ubaldi FM, Velasco JG, Ata B, Blockeel C, Conforti A, Esteves SC, Fatemi HM, Gianaroli L, Grynberg M, Humaidan P, Lainas GT, La Marca A, Craig LB, Lathi R, Norman RJ, Orvieto R, Paulson R, Pellicer A, Polyzos NP, Roque M, Sunkara SK, Tan SL, Urman B, Venetis C, Weissman A, Yarali H, Dahan MH. Correction to: The HERA (Hyper‑response Risk Assessment) Delphi consensus for the management of hyper‑responders in in vitro fertilization. J Assist Reprod Genet. 2024 Feb;41(2):519-520.

Quilichini J, Perol S, Cuisset L, Grotto S, Fouveaut C, Barbot JC, Verebi C, Jordan P, Héron D, Molina-Gomes D, Pipiras E, Grynberg M, Catteau-Jonard S, Touraine P, Christin-Maître S, Plu-Bureau G, El Khattabi L, Bienvenu T. Stratification of the risk of ovarian dysfunction by studying the complexity of intermediate and premutation alleles of the FMR1 gene. Am J Med Genet A. 2024 Apr;194(4):e63479.

Lafraoui I, Heddar A, Cantalloube A, Braham I, Peigné M, Beneteau C, Gricourt S, Poirsier C, Legrand S, Stoeva R, Metayer-Amelot L, Lobersztajn A, Lebrun S, Gruchy N, Abdennebi I, Cedrin-Durnerin I, Fernandez H, Luton D, Torre A, Zagdoun L, Chevalier N, Khrouf M, Mahmoud K, Epelboin S, Catteau-Jonard S, Misrahi M. Genetic Landscape of a Cohort of 120 Patients with Diminished Ovarian Reserve: Correlation with Infertility. Int J Mol Sci. 2024 Nov 6;25(22):11915.

Sellami I, Barbotin AL, Bernard V, Robin G, Catteau-Jonard S, Sonigo C, Peigné M. Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception. Semin Reprod Med. 2024 Mar;42(1):25-33.

Sonigo C, Robin G, Boitrelle F, Fraison E, Sermondade N, Mathieu d’Argent E, Bouet PE, Dupont C, Creux H, Peigné M, Pirrello O, Trombert S, Lecorche E, Dion L, Rocher L, Arama E, Bernard V, Monnet M, Miquel L, Birsal E, Haïm-Boukobza S, Plotton I, Ravel C, Grzegorczyk-Martin V, Huyghe É, Dupuis HGA, Lefebvre T, Leperlier F, Bardet L, Lalami I, Robin C, Simon V, Dijols L, Riss J, Koch A, Bailly C, Rio C, Lebret M, Jegaden M, Fernandez H, Pouly JL, Torre A, Belaisch-Allart J, Antoine JM, Courbiere B. First-line management of infertile couple. Guidelines for clinical practice of the French College of Obstetricians and Gynecologists 2022]. Gynecol Obstet Fertil Senol. 2024 May;52(5):305-335.

2023

Feferkorn I, Santos-Ribeiro S, Ubaldi FM, Velasco JG, Ata B, Blockeel C, Conforti A, Esteves SC, Fatemi HM, Gianaroli L, Grynberg M, Humaidan P, Lainas GT, La Marca A, Craig LB, Lathi R, Norman RJ, Orvieto R, Paulson R, Pellicer A, Polyzos NP, Roque M, Sunkara SK, Tan SL, Urman B, Venetis C, Weissman A, Yarali H, Dahan MH. The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization. J Assist Reprod Genet. 2023 Nov;40(11):2681-2695.

Peigné M, Bernard V, Dijols L, Creux H, Robin G, Hocké C, Grynberg M, Dewailly D, Sonigo C. Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis. Hum Reprod. 2023 Sep 5;38(9):1789-1806.

Santulli P, Dupont C, Achour-Chneiweiss N, Drouineaud V, Grynberg M, Eustache F, Peigné M, Sifer C, Llabador MA, Sermondade N, Rivet Danon D, Lévy R, Epelboin S, d’Argent EM, Patrat C. [News in assisted reproductive technologies after French Bioethic law of 2021 August]. Gynecol Obstet Fertil Senol. 2023 Sep;51(9):428-433.

Mayeur A, Benaloun E, Benguigui J, Duperier C, Hesters L, Chatzovoulou K, Monnot S, Grynberg M, Steffann J, Frydman N, Sonigo C. Preimplantation genetic testing for mitochondrial DNA mutation: ovarian response to stimulation, outcomes and follow-up. Reprod Biomed Online. 2023 Jul;47(1):61-69.

Dervin T, Ranisavjevic N, Laot L, Mayeur A, Duperier C, Steffann J, Borghese R, Stoppa-Lyonnet D, Frydman N, Benachi A, Sonigo C, Grynberg M. Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience. J Assist Reprod Genet. 2023 Jun;40(6):1381-1390.

Rodolakis A, Scambia G, Planchamp F, Acien M, Di Spiezio Sardo A, Farrugia M, Grynberg M, Pakiž M, Pavlakis K, Vermeulen N, Zannoni G, Zapardiel I, Tryde Macklon KL. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Facts Views Vis Obgyn. 2023 Mar;15(1):3-23.

Grynberg M, Pytel S, Peigne M, Sonigo C. The follicular output rate in normo-ovulating women undergoing ovarian stimulation is increased after unilateral oophorectomy. Hum Reprod. 2023 Jun 1;38(6):1162-1167.

Puy V, Dupeux M, Mayeur A, Grynberg M, Benoit A, Bendayan M, Zhegari F, Hesters L, Gallot V, Prevot S, Frydman N, Sonigo C. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation. Hum Reprod. 2023 May 2;38(5):860-871.

El Moujahed L, Philis R, Grynberg M, Laot L, Mur P, Amsellem N, Mayeur A, Benoit A, Rakrouki S, Sifer C, Peigné M, Sonigo C. Response to Ovarian Stimulation for Urgent Fertility Preservation before Gonadotoxic Treatment in BRCA-Pathogenic-Variant-Positive Breast Cancer Patients. Cancers (Basel). 2023 Jan 31;15(3):895.

Rodolakis A, Scambia G, Planchamp F, Acien M, Di Spiezio Sardo A, Farrugia M, Grynberg M, Pakiz M, Pavlakis K, Vermeulen N, Zannoni G, Zapardiel I, Macklon KLT. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Hum Reprod Open. 2023 Feb 6;2023(1):hoac057.

Sellami I, Mayeur A, Benoit A, Zeghari F, Peigné M, Roufael J, Grynberg M, Sonigo C Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM. J Assist Reprod Genet. 2023 Mar;40(3):473-480.

Rodolakis A, Scambia G, Planchamp F, Acien M, Di Spiezio Sardo A, Farrugia M, Grynberg M, Pakiz M, Pavlakis K, Vermeulen N, Zannoni G, Zapardiel I, Macklon KLT.  ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Int J Gynecol Cancer. 2023 Feb 6;33(2):208-222.

Grynberg M, Cedrin-Durnerin I, Raguideau F, Herquelot E, Luciani L, Porte F, Verpillat P, Helwig C, Schwarze JE, Paillet S, Castello-Bridoux C, D’Hooghe T, Benchaïb M.  Comparative effectiveness of gonadotropins used for ovarian stimulation during assisted reproductive technologies (ART) in France: A real-world observational study from the French nationwide claims database (SNDS). Best Pract Res Clin Obstet Gynaecol. 2023 Jun;88:102308.

Grzegorczyk-Martin V, Roset J, Di Pizio P, Fréour T, Barrière P, Pouly JL, Grynberg M, Parneix I, Avril C, Pacheco J, Grzegorczyk TM. Correction to: Adaptive data-driven models to best predict the likelihood of live birth as the IVF cycle moves on and for each embryo transfer. J Assist Reprod Genet. 2023 Feb;40(2):429.

Ferrier C, Hini JD, Gaillard T, Grynberg M, Kolanska K, Dabi Y, Nyangoh Timoh K, Lavoue V, Roman H, Darai E, Bendifallah S. First-line surgery vs first-line ART to manage infertility in women with deep endometriosis without bowel involvement: A multi-centric propensity-score matching comparison. Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:184-190.

Sonigo C, Amsellem N, Mayeur A, Laup L, Pistilli B, Delaloge S, Eustache F, Sifer C, Rakrouki S, Benoit A, Peigné M, Grynberg M Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer. Fertil Steril. 2023 Mar;119(3):465-473.

Peigné M, de Mouzon J, Khiel A, Fraissinet A, Maget V, Saïas-Magnan J, Mathieu-D’Argent E, Gervereau O, Letur H. Donated-embryo pregnancies are associated with increased risk of hypertensive disorders even for young recipients: a retrospective matched-cohort study. Fertil Steril. 2023 Jan;119(1):69-77.

2022

Laot L, Sonigo C, Nobre J, Benachi A, Dervin T, El Moujahed L, Mayeur A, Stoppa-Lyonnet D, Steffann J, Grynberg M. Should Preimplantation Genetic Testing (PGT) Systematically Be Proposed to BRCA Pathogenic Variant Carriers? Cancers (Basel). 2022 Nov 24; 14(23): 5769.

Rose M, Jodoin A, Duros S, Sonigo C, Grynberg M, Polak M, da Costa S, Bidet M. Fertility preservation in teenage girls, for non- oncological indications. J Gynecol Obstet Hum Reprod. 2022 Nov; 51(9): 102449.

Rives N, Courbière B, Almont T, Kassab D, Berger C, Grynberg M, Papaxanthos A, Decanter C, Elefant E, Dhedin N, Barraud-Lange V, Béranger MC, Demoor-Goldschmidt C, Frédérique N, Bergère M, Gabrel L, Duperray M, Vermel C, Hoog-Labouret N, Pibarot M, Provansal M, Quéro L, Lejeune H, Methorst C, Saias J, Véronique-Baudin J, Giscard d’Estaing S, Farsi F, Poirot C, Huyghe É. What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines. Eur J Cancer. 2022 Sep; 173: 146-166.

Sonigo C, Amsellem N, Mayeur A, Laup L, Pistilli B, Delaloge S, Eustache F, Sifer C, Rakrouki S, Benoit A, Peigné M, Grynberg M. Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer. Fertil Steril. 2022 Dec 3: S0015-0282(22)02048-9.

Grzegorczyk-Martin V, Roset J, Di Pizio P, Fréour T, Barrière P, Pouly JL, Grynberg M, Parneix I, Avril C, Pacheco J, Grzegorczyk TM. Adaptive data-driven models to best predict the likelihood of live birth as the IVF cycle moves on and for each embryo transfer. J Assist Reprod Genet. 2022 Aug; 39(8): 1937-1949.

Lalami I, Labrosse J, Cedrin-Durnerin I, Comtet M, Vinolas C, Krief F, Sifer C, Peigne M, Grynberg M. Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger? Reprod Biol Endocrinol. 2022 Jun 11; 20(1): 87.

Raad J, Sonigo C, Benoit A, Cedrin-Durnerin I, Sifer C, Sermondade N, Grynberg M. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation. Hum Reprod. 2022 Jun 30; 37(7): 1480-1488.

Bry-Gauillard H, Belin F, Vinolas C, Renoult-Pierre P, Massin N, Young J, Sifer C, Grynberg M. Live birth after in-vitro maturation of oocytes in a patient with specific ovarian insufficiency caused by long-term mitotane treatment for adrenocortical carcinoma. Reprod Biomed Online. 2022 Feb; 44(2): 304-309.

Carles M, Sonigo C, Binois O, Hesters L, Steffann J, Romana S, Frydman N, Mayeur A. Second biopsy for embryos with inconclusive results after preimplantation genetic testing: Impact on pregnancy outcomes. J Gynecol Obstet Hum Reprod. 2022 Oct; 51(8): 102436.

Fiot E, Alauze B, Donadille B, Samara-Boustani D, Houang M, De Filippo G, Bachelot A, Delcour C, Beyler C, Bois E, Bourrat E, Bui Quoc E, Bourcigaux N, Chaussain C, Cohen A, Cohen-Solal M, Da Costa S, Dossier C, Ederhy S, Elmaleh M, Iserin L, Lengliné H, Poujol-Robert A, Roulot D, Viala J, Albarel F, Bismuth E, Bernard V, Bouvattier C, Brac A, Bretones P, Chabbert-Buffet N, Chanson P, Coutant R, de Warren M, Demaret B, Duranteau L, Eustache F, Gautheret L, Gelwane G, Gourbesville C, Grynberg M, Gueniche K, Jorgensen C, Kerlan V, Lebrun C, Lefevre C, Lorenzini F, Manouvrier S, Pienkowski C, Reynaud R, Reznik Y, Siffroi JP, Tabet AC, Tauber M, Vautier V, Tauveron I, Wambre S, Zenaty D, Netchine I, Polak M, Touraine P, Carel JC, Christin-Maitre S, Léger J. Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol). Orphanet J Rare Dis. 2022 Jul 12;17(Suppl 1):261.

2021 :

Herbemont C, Labrosse J, Bennani-Smires B, Cedrin-Durnerin I, Peigne M, Sermondade N, Sarandi S, Vivot A, Vicaut E, Talib Z, Grynberg M, Sifer C. Impact of oxygen tension according to embryo stage of development: a prospective randomized study. Sci Rep. 2021 Nov 16; 11(1): 22313.

Hours A, Toussaint A, De Castelbajac V, Sautter C, Borghese J, Frank S, Coussy F, Laas E, Grandal B, Dumas E, Daoud E, Guerin J, Balezeau T, Feron JG,  Fourchotte V, Kirova Y, Lerebours F, Pierga JY, Guillot E, Santulli P, Grynberg M, Sonigo C, Reyrat E, Soibinet-Oudot P, Reyal F, Hamy AS. Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy. Front Oncol. 2021 Sep 28; 11: 701620.

Carbonnel M, Layoun L, Poulain M, Tourne M, Murtada R, Grynberg M, Feki A, Ayoubi JM. Serous Borderline Ovarian Tumor Diagnosis, Management and Fertility Preservation in Young Women. J Clin Med. 2021 Sep 18; 10(18): 4233.

Sonigo C, Mayeur A, Sadoun M, Pinto M, Benguigui J, Frydman N, Monnot S, Benachi A, Steffann J, Grynberg M. What is the threshold of mature oocytes to obtain at least one healthy transferable cleavage-stage embryo after preimplantation genetic testing for fragile X syndrome? Hum Reprod. 2021 Oct 18; 36(11): 3003-3013.

Christin-Maitre S, Givony M, Albarel F, Bachelot A, Bidet M, Blanc JV,  Bouvattier C, Brac de la Perrière A, Catteau-Jonard S, Chevalier N, Carel JC,  Coutant R, Donadille B, Duranteau L, El-Khattabi L, Hugon-Rodin J, Houang M, Grynberg M, Kerlan V, Leger J, Misrahi M, Pienkowski C, Plu-Bureau G, Polak M,  Reynaud R, Siffroi JP, Sonigo C, Touraine P, Zenaty D. Position statement on the diagnosis and management of premature/primary ovarian insufficiency (except Turner Syndrome). Ann Endocrinol (Paris). 2021 Dec; 82(6): 555-571.

De Vos M, Grynberg M, Ho TM, Yuan Y, Albertini DF, Gilchrist RB. Perspectives on the development and future of oocyte IVM in clinical practice. J Assist Reprod Genet. 2021 Jun; 38(6): 1265-1280.

de Bovis C, Baret C, Grynberg M, Freour T. Intérêt de la théorie des organisations à haute fiabilité en Assistance Médicale à la Procréation (AMP)  [Relevance of the theory of High Reliability Organizations in Assisted Reproductive Technology]. Gynecol Obstet Fertil Senol. 2021 Jun 16: S2468-7189(21)00158-6.

Orvieto R, Venetis CA, Fatemi HM, D’Hooghe T, Fischer R, Koloda Y, Horton M,  Grynberg M, Longobardi S, Esteves SC, Sunkara SK, Li Y, Alviggi C. Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus. Front Endocrinol (Lausanne). 2021 May 10; 12: 675670.

Grynberg M, Labrosse J, Bennani Smires B, Sifer C, Peigne M, Sonigo C. Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women? Hum Reprod. 2021 Jun 18; 36(7): 1941-1947.

Gruca A, Ziemska-Legiecka J, Jarnot P, Sarnowska E, Sarnowski TJ, Grynberg M. Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development. BMC Bioinformatics. 2021 Apr 8; 22(1): 182.

Mayeur A, Puy V, Windal V, Hesters L, Gallot V, Benoit A, Grynberg M, Sonigo C, Frydman N. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience. J Assist Reprod Genet. 2021 Jul; 38(7): 1767-1775.

Labrosse J, Peigné M, Eustache F, Sifer C, Grynberg M, Cedrin-Durnerin I. Women utilizing oocyte donation have a decreased live birth rate if they displayed a low progesterone level in a previous hormonal replacement mock cycle. J Assist Reprod Genet. 2021 Mar; 38(3): 605-612.

Epelboin S, Labrosse J, De Mouzon J, Fauque P, Gervoise-Boyer MJ, Levy R, Sermondade N, Hesters L, Bergère M, Devienne C, Jonveaux P, Ghosn J, Pessione F. Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study. PLoS Med. 2021 Nov 30; 18(11): e1003857.

Chatzovoulou K, Mayeur A, Gigarel N, Jabot-Hanin F, Hesters L, Munnich A, Frydman N, Bonnefont JP, Steffann J. Mitochondrial DNA mutations do not impact early human embryonic development. Mitochondrion. 2021 May; 58: 59-63.

Herbemont C, Mnallah S, Bennani-Smires B, Peigne M, Cedrin-Durnerin I,  Grynberg M, Sifer C. Cryopreservation of small numbers of human spermatozoa in a Stripper tip: Report of the first live-birth worldwide. Cryobiology. 2021 Apr; 99: 103-105.

M’kacher R, Colicchio B, Marquet V, Borie C, Najar W, Hempel WM,  Heidingsfelder L, Oudrhiri N, Al Jawhari M, Wilhelm-Murer N, Miguet M, Dieterlen A, Deschênes G, Tabet AC, Junker S, Grynberg M, Fenech M, Bennaceur-Griscelli A, Voisin P, Carde P, Jeandidier E, Yardin C. Telomere aberrations, including telomere loss, doublets, and extreme shortening, are increased in patients with infertility. Fertil Steril. 2021 Jan; 115(1): 164-173.

Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, Mathieu D’argent E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2021 Jan; 256: 492-501.

2020 :

Herbemont C, Labrosse J, Bennani-Smires B, Cedrin-Durnerin I, Peigne M, Sermondade N, Sarandi Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, Marca A, Lainas G, Clef NL, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N, Broekmans F. Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020 Dec 29; 2020(4): hoaa067.

Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Huchon C, Bourdel N, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, Mathieu D’argent E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers. J Gynecol Obstet Hum Reprod. 2020 Nov 4: 101965.

Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, D’argent Mathieu E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation. J Gynecol Obstet Hum Reprod. 2020 Nov 2: 101966.

Sermondade N, Grynberg M, Comtet M, Valdelievre C, Sifer C, Sonigo C. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible. Sci Rep. 2020 Oct 29; 10(1): 18555.

Courbiere B, Lacan A, Grynberg M, Grelat A, Rio V, Arbo E, Solignac C. Psychosocial and professional burden of Medically Assisted Reproduction (MAR): Results from a French survey. PLoS One. 2020 Sep 24; 15(9): e0238945.

Ferrier C, Boujenah J, Poncelet C, Chabbert-Buffet N, Mathieu D’Argent E, Carbillon L, Grynberg M, Darai E, Bendifallah S. Use of the EFI score in endometriosis-associated infertility: A cost-effectiveness study. Eur J Obstet Gynecol Reprod Biol. 2020 Oct; 253: 296-303.

Creux H, Diaz M, Grynberg M, Papaxanthos-Roche A, Chansel-Debordeaux L, Jimenez C, Frantz S, Chevalier N, Takefman J, Hocké C. National survey on the opinions of French specialists in assisted reproductive technologies about social issues impacting the future revision of the French Bioethics laws. J Gynecol Obstet Hum Reprod. 2020 Nov; 49(9): 101902.

Mayeur A, Binois O, Gallot V, Hesters L, Benoit A, Oppenheimer A, Presse M, Zeghari F, BenguigUi J, Grynberg M, Frydman N, Sonigo C. First follow-up of art pregnancies in the context of the COVID-19 outbreak. Eur J Obstet Gynecol Reprod Biol. 2020 Oct; 253: 71-75.

Grynberg M, Jacquesson L, Sifer C. In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency. Fertil Steril. 2020 Oct; 114(4): 848-853.

Sonigo C, Le Conte G, Boubaya M, Ohanyan H, Pressé M, El Hachem H, Cedrin-Durnerin I, Benoit A, Sifer C, Sermondade N, Grynberg M. Priming Before In Vitro Maturation Cycles in Cancer Patients Undergoing Urgent Fertility Preservation: a Randomized Controlled Study. Reprod Sci. 2020 Dec; 27(12): 2247-2256.

Alviggi C, Esteves SC, Orvieto R, Conforti A, La Marca A, Fischer R, Andersen CY, Bühler K, Sunkara SK, Polyzos NP, Strina I, Carbone L, Bento FC, Galliano D, Yarali H, Vuong LN, Grynberg M, Drakopoulos P, Xavier P, Llacer J, Neuspiller F, Horton M, Roque M, Papanikolaou E, Banker M, Dahan MH, Foong S, Tournaye H, Blockeel C, Vaiarelli A, Humaidan P, Ubaldi FM; POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) group. COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. Reprod Biol Endocrinol. 2020 May 13; 18(1): 45.

Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G, Le Clef N, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N, Broekmans F. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open. 2020 May 1; 2020(2): hoaa009.

Mayeur A, Ahdad N, Hesters L, Grynberg M, Romana S, Sonigo C, Frydman N. Does the prognosis after PGT for structural rearrangement differ between female and male translocation carriers? Reprod Biomed Online. 2020 May; 40(5): 684-692.

Affdal AO, Grynberg M, Hessissen L, Ravitsky V. Impact of legislation and public funding on oncofertility: a survey of Canadian, French and Moroccan pediatric hematologists/oncologists. BMC Med Ethics. 2020 Apr 3; 21(1): 25.

Grynberg M, Mayeur Le Bras A, Hesters L, Gallot V, Frydman N. First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer. Ann Oncol. 2020 Apr; 31(4): 541-542.

Sonigo C, Bajeux J, Boubaya M, Eustache F, Sifer C, Lévy V, Grynberg M, Sermondade N. In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions. Hematol Oncol. 2020 Oct; 38(4): 560-564.

Benoit A, Grynberg M, Morello R, Sermondade N, Grandazzi G, Moutel G. Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial. BMJ Open. 2020 Feb 10; 10(2): e031739.

Puy V, Mayeur A, Levy A, Hesters L, Raad J, Monnot S, Steffann J, Frydman N. CTG Expansion in the DMPK Gene: Semen Quality Assessment and Outcome of Preimplantation Genetic Diagnosis. J Clin Endocrinol Metab. 2020 Mar 1; 105(3): dgaa041.

2019 :

Esteves SC, Alviggi C, Humaidan P, Fischer R, Andersen CY, Conforti A, Bühler K, Sunkara SK, Polyzos NP, Galliano D, Grynberg M, Yarali H, Özbek IY, Roque M, Vuong LN, Banker M, Rienzi L, Vaiarelli A, Cimadomo D, Ubaldi FM. The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists. Front Endocrinol (Lausanne). 2019 Nov 20; 10: 814.

Benoit L, Boujenah J, Poncelet C, Grynberg M, Carbillon L, Nyangoh Timoh K, Touleimat S, Mathieu D’Argent E, Jayot A, Owen C, Lavoue V, Roman H, Darai E, Bendifallah S. Predicting the likelihood of a live birth for women with endometriosis-related infertility. Eur J Obstet Gynecol Reprod Biol. 2019 Nov; 242: 56-62.

Herbemont C, Mnallah S, Grynberg M, Sifer C. [Prospective comparison of different techniques for cryopreservation of small numbers of human spermatozoa]. Gynecol Obstet Fertil Senol. 2019 Nov; 47(11): 797-801.

Ranisavljevic N, Raad J, Anahory T, Grynberg M, Sonigo C. Embryo transfer strategy and therapeutic options in infertile patients with thin endometrium: a systematic review. J Assist Reprod Genet. 2019 Nov; 36(11): 2217-2231.

Sonigo C, Beau I, Binart N, Grynberg M. The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage. Int J Mol Sci. 2019 Oct 27; 20(21): 5342.

Grynberg M, Sermondade N. Fertility preservation: should we reconsider the terminology? Hum Reprod. 2019 Oct 2; 34(10): 1855-1857.

Stoeklé HC, Bollet M, Cobat A, Charlier P, Bloch OC, Flatot J, Draghi C, Tolyan V, Hervé C, Desvaux P, Uzan L, Grynberg M, Alcaïs A, Tolédano A, Vogt G. French-style genetics v. 2.0: The « e-CohortE » project. Clin Genet. 2019 Oct; 96(4): 330-340.

Scheffer JB, Scheffer BB, Carvalho RF, Aguiar AP, Lozano DHM, Labrosse J, Grynberg M. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol. JBRA Assist Reprod. 2019 Aug 22; 23(3): 239-245.

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Daraï E, Chabbert-Buffet N, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, Thibault MR, Ferron G, Devouassoux M, Kurtz JE, Provansal M, Namer M, Joly F, Pujade-Lauraine  E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers. Eur J Cancer. 2019 Jul; 116: 35-44.

Sonigo C, Beau I, Binart N, Grynberg M. Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications. Clin Med Insights Reprod Health. 2019 Jun 14; 13: 1179558119854755.

Sonigo C, Sermondade N, Calvo J, Benard J, Sifer C, Grynberg M. Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients. Eur J Obstet Gynecol Reprod Biol X. 2019 May 11; 4: 100049.

Grynberg M, Labrosse J. Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria. Front Endocrinol (Lausanne). 2019 Apr 16; 10: 246.

Cédrin-Durnerin I, Isnard T, Mahdjoub S, Sonigo C, Seroka A, Comtet M, Herbemont C, Sifer C, Grynberg M. Serum progesterone concentration and live birth rate in frozen-thawed embryo transfers with hormonally prepared endometrium. Reprod Biomed Online. 2019 Mar; 38(3): 472-480.

Pistilli B, Mazouni C, Zingarello A, Faron M, Saghatchian M, Grynberg M, Spielmann M, Kerbrat P, Roché H, Lorgis V, Bachelot T, Campone M, Levy C, Gonçalves A, Lesur A, Veyret C, Vanlemmens L, Lemonnier J, Delaloge S. Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials. Clin Breast Cancer. 2019 Feb; 19(1): 63-70.

Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, Grynberg M. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation. Fertil Steril. 2019 Feb; 111(2): 357-362.

Grynberg M, Dagher Hayeck B, Papanikolaou EG, Sifer C, Sermondade N, Sonigo C. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro. Hum Reprod. 2019 Feb 1; 34(2): 374-379.

Herbemont C, El Kouhen I, Brax A, Vinolas C, Dagher-Hayeck B, Comtet M, Calvo J, Sarandi S, Grynberg M, Cédrin-Durnerin I, Sifer C. [Dual trigger with gonadotropin-releasing hormone agonist and hCG to improve oocyte maturation rate]. Gynecol Obstet Fertil Senol. 2019 Jul-Aug; 47(7-8): 568-573.

Papanikolaou EG, Timotheou E, Tatsi P, Janssens H, Grynberg M, Athanasiadis A, Zafeirati C, Najdecki R, Petousis S. COMFFETI, Combined Fresh and Frozen Embryo Transfers per Individual: A New Index of Quality Control for The Performance of emberyologic Labs in The Emerging Era of Segmentation of Cycle and Freeze-All Strategy. Int J Fertil Steril. 2019 Jan; 12(4): 339-342.

Sonigo C, Beau I, Grynberg M, Binart N. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J. 2019 Jan; 33(1): 1278-1287.

Victoria M, Labrosse J, Krief F, Cédrin-Durnerin I, Comtet M, Grynberg M. Anti Müllerian Hormone: More than a biomarker of female reproductive function. J Gynecol Obstet Hum Reprod. 2019 Jan; 48(1): 19-24.

Mayeur A, Ahdad N, Hesters L, Brisset S, Romana S, Tosca L, Tachdjian G, Frydman N. Chromosomal translocations and semen quality: A study on 144 male translocation carriers. Reprod Biomed Online. 2019 Jan; 38(1): 46-55.

Sonigo C, Grynberg M, Bringer S, Sermondade N. Oncofertilité et cancer du sein [Oncofertility and breast cancer]. Bull Cancer. 2019 Dec;106(12S1):S43-S52.

2018:

Herbemont C, Chekroune S, Bonan S, Cedrin-Durnerin I, Vivot A, Sonigo C, Boujenah J, Grynberg M, Sifer C. Impact of post-warming culture duration on clinical outcomes of vitrified good-quality blastocyst transfers: a prospective randomized study. Fertil Steril. 2018 Dec; 110(7): 1290-1297.

Grynberg M, Murphy C, Doré C, Fresneau L, Paillet S, Petrica N, Frédérique M,  Ravonimbola H. A cost-effectiveness analysis comparing the originator follitropin alfa to its biosimilars in patients undergoing a medically assisted reproduction  program from a French perspective. J Med Econ. 2018 Nov 21: 1-15.

Scheffer JAB, Scheffer B, Scheffer R, Florencio F, Grynberg M, Lozano DM. Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF? JBRA Assist Reprod. 2018 Sep 1; 22(3): 215-220.

Vinolas C, Raad J, Sonigo C, Sifer C, Sermondade N, Grynberg M. Medical techniques of fertility preservation in the male and female. J Visc Surg. 2018 Jun; 155 Suppl 1: S3-S9.

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]. Bull Cancer. 2018 Mar; 105(3): 299-314.

Papanikolaou EG, Yarali H, Timotheou E, Grynberg M, Zafeiratis O, Tournaye H, Najdecki R. A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol. Front Endocrinol (Lausanne). 2018 Mar 1; 9: 25.

Grynberg M, Sonigo C, Santulli P. Fertility Preservation in Women. N Engl J Med. 2018 Jan 25; 378(4): 400.

Bénard J, Sermondade N, Grynberg M. Fertility Preservation in Endocrine Disorders during Transition for Girls. Endocr Dev. 2018; 33: 128-148.

Raad J, Sonigo C, Tran C, Sifer C, Durnerin IC, Grynberg M. Oocyte vitrification for preserving fertility in patients with endometriosis: first observational cohort study… and many unresolved questions. Letter to the Editor.  Eur J Obstet Gynecol Reprod Biol. 2018 Jan; 220: 140-141.

Sonigo C, Jankowski S, Yoo O, Trassard O, Bousquet N, Grynberg M, Beau I, Binart N. High-throughput ovarian follicle counting by an innovative deep learning approach. Sci Rep. 2018 Sep 10;8(1):13499.

Vinolas C, Raad J, Sonigo C, Sifer C, Sermondade N, Grynberg M. Medical techniques of fertility preservation in the male and female. J Visc Surg. 2018 Jun; 155 Suppl 1: S3-S9.

Grynberg M. The challenges of fertility preservation in cancer patients: an interview with Michael Grynberg. Future Oncol. 2018 Mar; 14(6): 497-498.

Grynberg M, Raad J, Comtet M, Vinolas C, Cédrin-Durnerin I, Sonigo C. Fertility preservation in BRCA-mutated women: when and how? Future Oncol. 2018 Feb;14(5):483-490.

Sonigo C, Comtet M, Duros S, Sifer C, Sermondade N, Grynberg M. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin’s lymphoma when compared with breast cancer candidates for fertility preservation. J Assist Reprod Genet. 2018 Jan;35(1):91-97.

El Hachem H, Sonigo C, Benard J, Presse M, Sifer C, Sermondade N, Grynberg M. Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation. PLoS One. 2018 Dec 6;13(12).

2017:

Herbemont C, Sarandi S, Boujenah J, Cedrin-Durnerin I, Sermondade N, Vivot A, Poncelet C, Grynberg M, Sifer C. Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality? Reprod Biomed Online. 2017 Nov; 35(5): 521-528.

Hugon-Rodin J, Sonigo C, Drummond D, Grynberg M, Rodin T, Plu-Bureau G, Tesniere A. [Learning the gynecological examination on low-fidelity simulation: Impact on the feelings of medical students]. Gynecol Obstet Fertil Senol. 2017 May; 45(5): 291-298.

Hugon-Rodin J, Sonigo C, Gompel A, Dodé C, Grynberg M, Binart N, Beau I. First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome. BMC Med Genet. 2017 Apr 26; 18(1): 44.

Scheffer JB, Scheffer BB, de Carvalho RF, Rodrigues J, Grynberg M, Mendez Lozano DH. Age as A Predictor of Embryo Quality Regardless of The Quantitative Ovarian Response. Int J Fertil Steril. 2017 Apr-Jun; 11(1): 40-46.

Gronier H, Sonigo C, Bringer S, Cedrin-Durnerin I, Hugues JN, Grynberg M. [Does accumulation of oocytes benefit to women with poor ovarian reserve? No]. Gynecol Obstet Fertil Senol. 2017 Mar; 45(3): 183-184.

Carde PP, Grynberg M, Poirot C, Glimelius B, Mounier N. Reply to C.F. Hess et al. J Clin Oncol. 2017 Jan 20; 35(3): 374.

Sonigo C, Sermondade N, Grynberg M. Letter in reply to « Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations ». Future Oncol. 2017 Mar; 13(7): 591-592.

Le Bras A, Hesters L, Gallot V, Tallet C, Tachdjian G, Frydman N. Shortening gametes co-incubation time improves live birth rate for couples with a history of fragmented embryos. Syst Biol Reprod Med. 2017 Oct; 63(5): 331-337.